OxyMinder
Analyzer, Gas, Oxygen, Gaseous-Phase. 510(k) K213948, from Bio-Med Devices, Inc. (Guilford, CT). Product code CCL, class 2.
As of Nov 17, 2026, K213948 is an FDA 510(k) held by Bio-Med Devices, Inc., substantially equivalent on Mar 17, 2022 after 90 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Mar 17, 2022
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe OxyMinder is intended for continuous monitoring of the concentration of oxygen being delivered to patients ranging from newborns to adults. This device can be used in the hospital and subacute settings. The monitor is not intended as a life supporting device or for diagnostics.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- MaxO2MEK153659 · Maxtec, LLC · Jun 10, 2016
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- OxyMinder Pro (10310)K251245 · Bio-Med Device, Inc. · Aug 11, 2025
Other CCL Clearances
The newest 510(k)s for the same product code; their median review was 112 days; see every CCL device- PRO2 Elite Plus Oxygen Analyzer (PRO2PLUS-1)K261389 · Salter Labs · Jul 30, 2026
- OxyMinder Pro (10310)K251245 · Bio-Med Device, Inc. · Aug 11, 2025
- Smart Check O2 (MA0236)K250002 · Life Spark Medical, LLC · Apr 24, 2025
- Maxtec MaxO2 ME+pK221734 · Maxtec, LLC · Apr 1, 2023
- Percent Oxygen SensorsK213933 · Careox, LLC · Aug 19, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 17, 2021
- Review panel
- Anesthesiology
- Regulation
- 21 CFR 868.1720
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files